1210950

Aurobindo Pharma Ltd — FEI 3004021229

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 21, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Medchal (India)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed
180921 CFR 211.160(a)Following/documenting laboratory controls
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation